
Marksans Pharma Limited has informed the Exchange regarding a press release dated January 23, 2023, titled "Marksans Pharma Limited announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution.".
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated January 23, 2023, titled "Marksans Pharma Limited announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution.".
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma